Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Infections, Respiratory Syncytial Virus

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Infections, Respiratory Syncytial Virus in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kato, M; Kimura, H; Kozawa, K; Morikawa, A; Nako, Y; Tachibana, A1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Infections, Respiratory Syncytial Virus

ArticleYear
Respiratory syncytial virus enhances the expression of CD11b molecules and the generation of superoxide anion by human eosinophils primed with platelet-activating factor.
    Intervirology, 2002, Volume: 45, Issue:1

    Topics: Eosinophils; Humans; Macrophage-1 Antigen; Platelet Activating Factor; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Superoxides

2002